These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18642461)

  • 21. Familial hypercholesterolaemia.
    Phillips T; Leigh IM
    J R Soc Med; 1987 Oct; 80(10):649-51. PubMed ID: 3320364
    [No Abstract]   [Full Text] [Related]  

  • 22. Defective LDL receptors that are common in a large population. Familial hypercholesterolaemia in South Africa.
    Gevers W; Casciola LA; Fourie AM; Sanan DA; Coetzee GA; van der Westhuyzen DR
    Biol Chem Hoppe Seyler; 1987 Oct; 368(10):1233-43. PubMed ID: 3322320
    [No Abstract]   [Full Text] [Related]  

  • 23. [Screening and treatment of children and adolescents with hypercholesterolemias and dyslipidemias].
    Sobra J
    Cas Lek Cesk; 1998 Feb; 137(3):67-72. PubMed ID: 9511274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for familial hypercholesterolaemia.
    Calonge N; Guirguis-Blake J
    BMJ; 2007 Sep; 335(7620):573-4. PubMed ID: 17884865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yellowish intertriginous plaques in a young girl: a clue to homozygous familial hypercholesterolaemia.
    Bhatia R; Chakraborty A; Durgapal P; Walia R; Kaur D
    Postgrad Med J; 2020 Nov; 96(1141):718. PubMed ID: 31911449
    [No Abstract]   [Full Text] [Related]  

  • 26. Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
    Minhas R; Humphries SE; Qureshi N; Neil HA;
    Heart; 2009 Apr; 95(7):584-7; discussion 587-91. PubMed ID: 19168470
    [No Abstract]   [Full Text] [Related]  

  • 27. [Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society].
    Cuchel M; Bruckert E; Ginsberg HN; Raal FJ; Santos RD; Hegele RA; Kuivenhoven JA; Nordestgaard BG; Descamps OS; Steinhagen-Thiessen E; Tybjaerg-Hansen A; Watts GF; Averna M; Boileau C; Borén J; Catapano AL; Defesche JC; Hovingh GK; Humphries SE; Kovanen PT; Masana L; Pajukanta P; Parhofer KG; Ray KK; Stalenhoef AF; Stroes E; Taskinen MR; Wiegman A; Wiklund O; Chapman MJ;
    Turk Kardiyol Dern Ars; 2015 Mar; 43 Suppl 1():1-14. PubMed ID: 27326442
    [No Abstract]   [Full Text] [Related]  

  • 28. Manifestations of familial hypercholesterolaemia.
    Gillett MJ; Burnett JR
    Intern Med J; 2005 Jan; 35(1):63-4. PubMed ID: 15667473
    [No Abstract]   [Full Text] [Related]  

  • 29. Homozygous familial hypercholesterolaemia.
    Kaushal R; Shama SK; Wali JF; Pande JN; Guleria JS
    J Assoc Physicians India; 1985 Oct; 33(10):659-60. PubMed ID: 4093368
    [No Abstract]   [Full Text] [Related]  

  • 30. Follow up after a family based genetic screening programme for familial hypercholesterolaemia: is screening alone enough?
    Van Maarle MC; Stouthard ME; Marang-Van De Mheen PJ; Klazinga NS; Bonsel GJ
    BMJ; 2002 Jun; 324(7350):1367-8. PubMed ID: 12052805
    [No Abstract]   [Full Text] [Related]  

  • 31. A new model of care for familial hypercholesterolaemia from Western Australia: closing a major gap in preventive cardiology.
    Watts GF; van Bockxmeer FM; Bates T; Burnett JR; Juniper A; O'Leary P
    Heart Lung Circ; 2010 Jul; 19(7):419-22. PubMed ID: 20363671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial hypercholesterolaemia.
    Gill PJ; Harnden A; Karpe F
    BMJ; 2012 May; 344():e3228. PubMed ID: 22581572
    [No Abstract]   [Full Text] [Related]  

  • 33. Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.
    Datta BN; McDowell IF; Rees A
    Curr Opin Lipidol; 2010 Aug; 21(4):366-71. PubMed ID: 20613514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial hypercholesterolaemia is underdiagnosed after AMI.
    Dorsch MF; Lawrance RA; Durham NP; Hall AS
    BMJ; 2001 Jan; 322(7278):111. PubMed ID: 11203728
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening, diagnosis, and treatment of familial hypercholesterolaemia: a call to action.
    Crea F
    Eur Heart J; 2022 Sep; 43(34):3185-3188. PubMed ID: 36068020
    [No Abstract]   [Full Text] [Related]  

  • 36. Familial hypercholesterolaemia: a look back, a look ahead.
    Hamilton-Craig I
    Med J Aust; 2005 Aug; 183(4):222; author reply 223. PubMed ID: 16097931
    [No Abstract]   [Full Text] [Related]  

  • 37. Monogenic primary hypercholesterolaemia in South Africa.
    Rubinsztein DC; van der Westhuyzen DR; Coetzee GA
    S Afr Med J; 1994 Jun; 84(6):339-44. PubMed ID: 7740380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnosis and management of familial hypercholesterolaemia.
    Marais AD; Firth JC
    Eur Rev Med Pharmacol Sci; 2005; 9(3):141-9. PubMed ID: 16080633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for familial hypercholesterolaemia. Funding is difficult to obtain but screening can be international.
    Tomlinson B; Lan IW; Hamilton-Craig I
    BMJ; 2001 Apr; 322(7293):1061-2. PubMed ID: 11349660
    [No Abstract]   [Full Text] [Related]  

  • 40. Familial hypercholesterolaemia: underdiagnosed and undertreated.
    Rees A
    Eur Heart J; 2008 Nov; 29(21):2583-4. PubMed ID: 18840878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.